BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT04303169-completion@plaintrial.com
DTSTAMP:20261029T024437Z
DTSTART;VALUE=DATE:20250924
SUMMARY:Substudy 02C: Safety and Efficacy of Pembrolizumab in Combination W
 ith Investigational Agents or Pembrolizumab Alone in Participants With Sta
 ge III Melanoma Who Are Candidates for Neoadjuvant Therapy (MK-3475-02C/KE
 YMAKER-U02) — estimated completion date
DESCRIPTION:Completed. Saved on your PlainTrial shortlist. Full trial recor
 d: https://plaintrial.com/trial/NCT04303169
URL:https://plaintrial.com/trial/NCT04303169
END:VEVENT
END:VCALENDAR